Bristol-Myers Squibb to Take Part in Goldman Sachs 40th Annual Global Healthcare Conference

Tuesday, June 4, 2019 12:23 pm EDT

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) will take part in Goldman Sachs 40th Annual Global Healthcare Conference on Tuesday, June 11, 2019, in Rancho Palos Verdes, CA. Chris Boerner, Executive Vice President, Chief Commercial Officer, will answer questions about the company at 11:00 a.m. ET (8:00 a.m. PT).

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedInTwitter, YouTube and Facebook.

Contact:

Media: Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com

Investors: Tim Power, 609-252-7509, timothy.power@bms.com

Privacy Policy
Business Wire NewsHQsm